(Q39738474)

14 September 2017

title

Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells (English)

1 reference

14 September 2017

0 references

1

1 reference

14 September 2017

E Pérez-Martín

2

1 reference

14 September 2017

C Gallardo

3

1 reference

14 September 2017

F J Salguero

4

1 reference

14 September 2017

B Borrego

5

1 reference

14 September 2017

A Lacasta

6

1 reference

14 September 2017

F Accensi

7

1 reference

14 September 2017

I Díaz

8

1 reference

14 September 2017

M Nofrarías

9

1 reference

14 September 2017

J Pujols

10

1 reference

14 September 2017

E Blanco

11

1 reference

14 September 2017

M Pérez-Filgueira

12

1 reference

14 September 2017

J M Escribano

13

1 reference

14 September 2017

F Rodríguez

14

1 reference

14 September 2017

language of work or name

English

0 references

publication date

14 June 2011

1 reference

14 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

33

1 reference

14 September 2017

page(s)

5379-5385

1 reference

Muscular gene transfer using nonviral vectors

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Direct gene transfer into nonhuman primate myofibers in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Immunologic basis of vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Induction of immune responses by DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

DNA vaccines: ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

DNA vaccines and their applications in veterinary practice: current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

DNA vaccination and gene therapy: optimization and delivery for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Current developments in viral DNA vaccines: shall they solve the unsolved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

DNA vaccines: recent developments and future possibilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Strategies for improved formulation and delivery of DNA vaccines to veterinary target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Targeting plasmid-encoded proteins to the antigen presentation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

inferred from DOI database lookup

7 January 2021

based on heuristic

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Single chain antibody fragments for the selective targeting of antigens to dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Characterization of five monoclonal antibodies specific for swine class II major histocompatibility antigens and crossreactivity studies with leukocytes of domestic animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Application of a monoclonal antibody recognizing protein p30 to detect African swine fever virus-infected cells in peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA for detection of antibody to African swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Monoclonal antibody 2F4/11 recognizes the alpha chain of a porcine beta 2 integrin involved in adhesion and complement mediated phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Cell culture propagation modifies the African swine fever virus replication phenotype in macrophages and generates viral subpopulations differing in protein p54

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Passively transferred African swine fever virus antibodies protect swine against lethal infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Porcine immune responses to African swine fever virus (ASFV) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

The role of antibody in protection against African swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

The immunological response of pigs and guinea pigs to antigens of African swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

How innate immune mechanisms contribute to antibody-enhanced viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Flavivirus Infection Enhancement in Macrophages: Radioactive and Biological Studies on the Effect of Antibody on Viral Fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Interferon-Gamma Production by African Swine Fever Virus-Specific Lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.084

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.05.084

1 reference

14 September 2017

1 reference